Palomar (NASDAQ:PLMR) Price Target Raised to $166.00

Palomar (NASDAQ:PLMR) had its price target raised by investment analysts at Keefe, Bruyette & Woods from $162.00 to $166.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ target price would suggest a potential upside of 13.78% from the stock’s current price.

A number of other analysts also recently weighed in on PLMR. Weiss Ratings upgraded shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, June 18th. JPMorgan Chase & Co. decreased their price objective on Palomar from $160.00 to $150.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 26th. Zacks Research cut Palomar from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th. Finally, Piper Sandler decreased their price objective on shares of Palomar from $151.00 to $132.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $149.50.

Palomar Stock Performance

NASDAQ PLMR traded up $0.60 on Wednesday, hitting $145.89. 74,288 shares of the company traded hands, compared to its average volume of 266,650. The business’s 50 day moving average price is $116.29 and its 200-day moving average price is $123.05. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31. Palomar has a 52-week low of $100.81 and a 52-week high of $147.58. The company has a market capitalization of $3.87 billion, a price-to-earnings ratio of 20.32 and a beta of 0.41.

Palomar (NASDAQ:PLMR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.17 by $0.14. The firm had revenue of $278.94 million during the quarter, compared to analysts’ expectations of $557.79 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The company’s revenue for the quarter was up 59.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.87 earnings per share. Equities analysts expect that Palomar will post 8.93 earnings per share for the current year.

Insiders Place Their Bets

In other Palomar news, President Jon Christianson sold 6,863 shares of Palomar stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $139.50, for a total transaction of $957,388.50. Following the sale, the president owned 66,478 shares of the company’s stock, valued at $9,273,681. The trade was a 9.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mac Armstrong sold 3,500 shares of the business’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $112.96, for a total transaction of $395,360.00. Following the transaction, the chief executive officer owned 329,388 shares in the company, valued at $37,207,668.48. The trade was a 1.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 22,977 shares of company stock worth $2,933,488. Corporate insiders own 3.70% of the company’s stock.

Institutional Investors Weigh In On Palomar

Several large investors have recently bought and sold shares of the stock. Geneos Wealth Management Inc. purchased a new stake in shares of Palomar in the 4th quarter valued at approximately $32,000. Kestra Advisory Services LLC purchased a new stake in Palomar during the 4th quarter worth about $33,000. Rockefeller Capital Management L.P. boosted its position in shares of Palomar by 81.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after acquiring an additional 132 shares in the last quarter. Parallel Advisors LLC raised its position in shares of Palomar by 638.3% during the 1st quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock worth $53,000 after acquiring an additional 383 shares in the last quarter. Finally, Frazier Financial Advisors LLC purchased a new stake in Palomar during the fourth quarter worth approximately $54,000. Hedge funds and other institutional investors own 90.25% of the company’s stock.

Trending Headlines about Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Palomar’s shares are benefiting from renewed optimism after the company recently raised its 2026 adjusted net income guidance, which helped fuel a sharp rally earlier in the week. Palomar Holdings (PLMR) Is Up 12.5% After Raising 2026 Adjusted Net Income Guidance – What’s Changed
• Positive Sentiment: Analyst commentary remains supportive overall, with Palomar continuing to carry a “Moderate Buy” consensus and a target price near current trading levels, suggesting expectations remain constructive.
• Neutral Sentiment: Zacks Research left its rating at “Hold” but slightly increased its Q4 2027 EPS estimate to $2.71 from $2.66, signaling some confidence in longer-term earnings power.
• Neutral Sentiment: Zacks also trimmed its Q2 2028 EPS estimate to $2.26 from $2.27 and its Q1 2028 estimate to $3.12 from $3.18, while reducing FY2027 EPS to $9.66 from $9.72, which is a small headwind but not a major change.
• Negative Sentiment: Insider selling by President Jon Christianson, who sold 6,863 shares under a pre-arranged 10b5-1 plan, may create some caution even though the sale was not necessarily a negative operating signal. Jon Christianson Sells 6,863 Shares of Palomar (NASDAQ:PLMR) Stock

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.